- Home
- DYN vs TRUP Comparison
DYN vs TRUP Comparison
Compare DYN & TRUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- TRUP
- Stock Information
- Founded
- DYN 1984
- TRUP 2000
- Country
- DYN United States
- TRUP United States
- Employees
- DYN N/A
- TRUP N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- TRUP Medical Specialities
- Sector
- DYN Health Care
- TRUP Health Care
- Exchange
- DYN Nasdaq
- TRUP Nasdaq
- Market Cap
- DYN 1.9B
- TRUP 1.9B
- IPO Year
- DYN 2020
- TRUP 2014
- Fundamental
- Price
- DYN $22.58
- TRUP $39.99
- Analyst Decision
- DYN Strong Buy
- TRUP Buy
- Analyst Count
- DYN 14
- TRUP 4
- Target Price
- DYN $34.93
- TRUP $55.50
- AVG Volume (30 Days)
- DYN 3.0M
- TRUP 385.9K
- Earning Date
- DYN 10-28-2025
- TRUP 11-06-2025
- Dividend Yield
- DYN N/A
- TRUP N/A
- EPS Growth
- DYN N/A
- TRUP N/A
- EPS
- DYN N/A
- TRUP 0.25
- Revenue
- DYN N/A
- TRUP $1,360,295,000.00
- Revenue This Year
- DYN N/A
- TRUP $13.17
- Revenue Next Year
- DYN N/A
- TRUP $7.90
- P/E Ratio
- DYN N/A
- TRUP $158.91
- Revenue Growth
- DYN N/A
- TRUP 13.11
- 52 Week Low
- DYN $6.36
- TRUP $31.00
- 52 Week High
- DYN $35.68
- TRUP $57.90
- Technical
- Relative Strength Index (RSI)
- DYN 74.06
- TRUP 29.95
- Support Level
- DYN $23.05
- TRUP $43.01
- Resistance Level
- DYN $25.00
- TRUP $44.78
- Average True Range (ATR)
- DYN 1.02
- TRUP 1.23
- MACD
- DYN 0.72
- TRUP -0.22
- Stochastic Oscillator
- DYN 78.24
- TRUP 12.11
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About TRUP Trupanion Inc.
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.